Talk:Turoctocog alfa

Route of administration?
Isn't the route of administration subcutaneous injection rather than intravenous infusion? — Preceding unsigned comment added by 190.236.204.121 (talk) 05:33, 10 August 2020 (UTC)
 * Per https://www.drugs.com/monograph/antihemophilic-factor-recombinant-pegylated-aucl.html, it's "For intravenous use after reconstitution only … Infuse antihemophilic factor (recombinant), PEGylated-aucl intravenously over a period of 1 to 15 minutes". The EMA says the same at https://www.ema.europa.eu/en/documents/product-information/novoeight-epar-product-information_en.pdf: "The recommended infusion rate for NovoEight is 1–2 ml/min". Hope that helps. --ἀνυπόδητος (talk) 08:57, 10 August 2020 (UTC)